To Investigate if Alpha-blocker Therapy (Alfuzosin) Increases Stone Free Rates and Improves Pain Control After ESWL (Extra-corporeal Shock Wave Lithotripsy) for Renal and Ureteric Stones.
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Alfuzosin (Primary)
- Indications Urinary calculi
- Focus Therapeutic Use
- 25 Oct 2016 New trial record